These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|No trial status on register||2004-005207-15||Low dose muscle relaxant in intubation in children||bad-data|
|Not reported||2005-000496-17||Atorvastatin in moderat active Crohns disease||2007-09-04||due-trials|
|Ongoing||2007-007661-20||Which is the optimal treatment for miscarriage with a gestational sac in the uterus and which factors can predict if the treatment will be successful?||not-yet-due|
|Completed, but no date Terminated||2008-000306-36||Nexavar in Relapsed Peripheral T-cell Non-Hodgkins Lymphoma||bad-data|
|Ongoing||2008-001871-31||Local steroid injection in the treatment of idiopathic carpal tunnel syndrome: A randomized double-blind placebo-controlled trial among patients planned for surgical treatment||not-yet-due|
|Ongoing||2010-018604-85||Randomized study of yohimbine treatment for type 2 diabetes patients carrying a specific genetic risk variant||not-yet-due|
|Ongoing||2011-001264-22||Eplerenone and spironolactone in male patients with ascites due to liver cirrhosis. A Swedish prospective randomized multicenter study of efficacy and endocrinologic side effects.||not-yet-due|
|Ongoing||2013-002895-42||Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma (GITS Ma...||not-yet-due|
|Ongoing||2013-004224-10||Prospective randomized trial comparing the effects of oxytocin and carbetocin on circulation and vascular tone at cesarean section||not-yet-due|
|Ongoing||2016-000235-40||Stopping anti-TNF treatment in Crohn’s and Colitis patients in remission||not-yet-due|
|Ongoing||2016-004120-39||An experimental pilot study on immune and inflammatory biomarkers in patients with advanced prostatecancer treated with degarelix vs. GnRH agonist and with cardiovascular disease||not-yet-due|
|Ongoing||2017-002008-28||A prospective open label study to evaluate||not-yet-due|